Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Non-GAAP net income: $4,747M in FY2025, up 4,192.0% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Non-GAAP net income | $ | 1,287.2 | $ | 1,036.3 | $ | 4,747.0 | $ | 110.6”
Source: Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (GAAP to Non-GAAP Reconciliations).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP net income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,747 | +4,192.0% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 111 | -97.2% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 3,968 | +2.9% | Form 8-K (ex-991_q42024.htm, filed 2025-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 3,855 | +53.4% | Form 8-K (ex-991_q42023.htm, filed 2024-02-05) ↗ |
| FY2021 | Dec 31, 2021 | 2,513 | -7.6% | Form 8-K (ex-991_q42022.htm, filed 2023-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 2,719 | +95.8% | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 1,389 | +31.2% | Form 8-K (ex-991_q42020.htm, filed 2021-02-01) ↗ |
| FY2018 | Dec 31, 2018 | 1,059 | +114.1% | Form 8-K (ex-991q42019.htm, filed 2020-01-30) ↗ |
| FY2017 | Dec 31, 2017 | 495 | +134.2% | Form 8-K (ex-991_q42018.htm, filed 2019-02-05) ↗ |
| FY2016 | Dec 31, 2016 | 211 | – | Form 8-K (ex-991_q42017.htm, filed 2018-01-31) ↗ |
Breakdown
What makes up non-GAAP net income
- Non-GAAP diluted earnings per share ($/sh)18.40 · FY2025
- Non-GAAP operating income ($M)5,263 · FY2025
- Non-GAAP combined R&D, AIPR&D and SG&A expenses ($M)5,118 · FY2025
- Non-GAAP cost of sales ($M)1,620 · FY2025
- Total pre-tax Non-GAAP adjustments (SBC, intangible amortization, contingent consideration & acquisition costs, $M)1,095 · FY2025
- Non-GAAP provision for income taxes ($M)991 · FY2025
- Non-GAAP total revenues (historical through FY2021, $M)7,573 · FY2021
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP net income ($M), annual FY2016–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-netinc
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.